Pulmonary surfactant-associated protein A2

BE0016550ProteinHumansSFTPA2

In presence of calcium ions, it binds to surfactant phospholipids and contributes to lower the surface tension at the air-liquid interface in the alveoli of the mammalian lung and is essential for normal respiration. It is acted on by 1 drug in DrugBank.

Gene name
SFTPA2
UniProtKB entry
Q8IWL1Swiss-Prot
Cellular location
Secreted
Residues / weight
248 residues · 26,169 Da
Also known as
35 kDa pulmonary surfactant-associated protein · Alveolar proteinosis protein · COLEC5 · Collectin-5 · PSAP

Resolves to

Pharmacology

What you can answer from here — as of September 03, 2024

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
5GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which approved drugs act on Pulmonary surfactant-associated protein A2, how selective are they, and which programs against it are still in active trials?

Create a free account or log in to explore the full data card.

Create Account